{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:10:31Z","timestamp":1759403431420,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007660","name":"University of Antwerp","doi-asserted-by":"publisher","award":["PS ID 30730"],"award-info":[{"award-number":["PS ID 30730"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012541","name":"Hercules Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","award":["151316","1861219N"],"award-info":[{"award-number":["151316","1861219N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2020.03.004","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T08:54:37Z","timestamp":1583744077000},"page":"3218-3226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcriptomic profiling of different responder types in adults after a Priorix\u00ae vaccination"],"prefix":"10.1016","volume":"38","author":[{"given":"Esther","family":"Bartholomeus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"De Neuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvid","family":"Suls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanne","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Keersmaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde","family":"Jansens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viggo","family":"Van Tendeloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Beutels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Laukens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benson","family":"Ogunjimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Mortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Meysman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"European centre for disease prevention and control. Vaccine schedule; 2019. https:\/\/vaccine-schedule.ecdc.europa.eu\/.","key":"10.1016\/j.vaccine.2020.03.004_b0005"},{"unstructured":"Center for Disease Control and prevention. Measles, Mumps, and Rubella (MMR) Vaccination: What Everyone Should Know; 2019.","key":"10.1016\/j.vaccine.2020.03.004_b0010"},{"key":"10.1016\/j.vaccine.2020.03.004_b0015","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.vaccine.2017.12.075","article-title":"Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine","volume":"36","author":"Seagle","year":"2018","journal-title":"Vaccine"},{"doi-asserted-by":"crossref","unstructured":"Haralambieva IH, Ovsyannikova IG, Pankratz VS, Richard B. The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches 2013;12:57\u201370. https:\/\/doi.org\/10.1586\/erv.12.134.The.","key":"10.1016\/j.vaccine.2020.03.004_b0020","DOI":"10.1586\/erv.12.134"},{"key":"10.1016\/j.vaccine.2020.03.004_b0025","doi-asserted-by":"crossref","DOI":"10.1007\/5584_2019_344","article-title":"Vaccination against measles, mumps, and rubella in the light of current epidemic threats: unjustified postponement","author":"Czajka","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2020.03.004_b0030","article-title":"Measles cases in Europe tripled from 2017 to 2018","volume":"364","author":"Thornton","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2020.03.004_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062149","article-title":"Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination","volume":"8","author":"Haralambieva","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2020.03.004_b0040","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1016\/j.vaccine.2018.08.010","article-title":"Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults","volume":"36","author":"McLean","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.004_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0188149","article-title":"Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology","volume":"12","author":"Haralambieva","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.004_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0160970","article-title":"Whole transcriptome profiling identifies CD93 and other plasma cell survival factor genes associated with measles-specific antibody response after vaccination","volume":"11","author":"Haralambieva","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.004_b0055","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/v7031113","article-title":"Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays","volume":"7","author":"Haralambieva","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2020.03.004_b0060","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.vaccine.2011.04.037","article-title":"A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine","volume":"29","author":"Haralambieva","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.004_b0065","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00251-004-0756-0","article-title":"HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine","volume":"56","author":"Ovsyannikova","year":"2005","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2020.03.004_b0070","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.vaccine.2007.01.020","article-title":"HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design","volume":"25","author":"Ovsyannikova","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.004_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0171261","article-title":"A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses","volume":"12","author":"Ovsyannikova","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.004_b0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/vim.2011.0051","article-title":"Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination","volume":"25","author":"Umlauf","year":"2012","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2020.03.004_b0085","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.vaccine.2020.03.004_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-28948-z","article-title":"GOATOOLS: A Python library for Gene Ontology analyses","volume":"8","author":"Klopfenstein","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.03.004_b0095","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1086\/598482","article-title":"Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to 16 years after their last vaccination","volume":"199","author":"Vandermeulen","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.004_b0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2567.2010.03263.x","article-title":"Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice","volume":"131","author":"Vandermeulen","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2020.03.004_b0105","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4161\/hv.7943","article-title":"Mumps outbreaks in high vaccinated populations: what makes good even better?","volume":"5","author":"Vandermeulen","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2020.03.004_b0110","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.vaccine.2004.02.001","article-title":"Outbreak of mumps in a vaccinated child population: a question of vaccine failure?","volume":"22","author":"Vandermeulen","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.004_b0115","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1016\/j.vaccine.2007.07.008","article-title":"Long-term persistence of antibodies after one or two doses of MMR-vaccine","volume":"25","author":"Vandermeulen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.004_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0172156","article-title":"Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens","volume":"12","author":"Mi","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.004_b0125","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1016\/j.vaccine.2004.07.022","article-title":"Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8\u201310-year-old children","volume":"23","author":"Duval","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.004_b0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2310\/7060.2005.12604","article-title":"Combined typhoid fever and hepatitis A vaccine: comparison of immunogenicity and safety to concomitant monovalent vaccine over 3 years","volume":"12","author":"Overbosch","year":"2006","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2020.03.004_b0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0264-410X(00)00166-3","article-title":"Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A\/B vaccine during the primary immunization course?","volume":"19","author":"Kallinowski","year":"2001","journal-title":"Vaccine"},{"unstructured":"Center for Disease Control and prevention. Monovalent vaccines\u2014ATTENUVAX\u00ae (measles vaccine), MUMPSVAX\u00ae (mumps vaccine) and MERUVAX\u00ae (rubella vaccine); 2009.","key":"10.1016\/j.vaccine.2020.03.004_b0140"},{"key":"10.1016\/j.vaccine.2020.03.004_b0145","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archpedi.161.3.294","article-title":"Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment","volume":"161","author":"LeBaron","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2020.03.004_b0150","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/S0264-410X(03)00053-7","article-title":"The effect of measles-mumps-rubella (MMR) immunization on the immune responses of previously immunized primary school children","volume":"21","author":"Rager-Zisman","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.004_b0155","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1016\/j.vaccine.2018.09.001","article-title":"Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders","volume":"36","author":"Bartholomeus","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.004_b0160","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1038\/ncomms7881","article-title":"APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages","volume":"6","author":"Sharma","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2020.03.004_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008080","article-title":"Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies","volume":"15","author":"Perelygina","year":"2019","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.vaccine.2020.03.004_b0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0300-9084(02)01431-1","article-title":"Regulation of virus-induced interferon-A genes","volume":"84","author":"Civas","year":"2002","journal-title":"Biochemie"},{"key":"10.1016\/j.vaccine.2020.03.004_b0175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/08916930310001602119","article-title":"Positive and negative control of virus-induced interferon-A gene expression","volume":"36","author":"Mespl\u00e8de","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.vaccine.2020.03.004_b0180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cytogfr.2009.07.005","article-title":"The role of differential expression of human interferon-A genes in antiviral immunity","volume":"20","author":"G\u00e9nin","year":"2009","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20303364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:23Z","timestamp":1759401743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20303364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":36,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X20303364"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptomic profiling of different responder types in adults after a Priorix\u00ae vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}